Skip to search.
 BSE Up 0.48% NSE Up 0.65%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
11.26 Down 0.52(4.41%) 28 Feb 2:30AM
|After Hours : 11.28 Up 0.02 (0.18%) 28 Feb 5:55AM
Add to Portfolio
Prev Close:11.78
Open:11.42
Bid:11.01 x 100
Ask:N/A
1y Target Est:10.50
Beta:0.01
Next Earnings Date:N/A
Day's Range:11.10 - 12.02
52wk Range:2.31 - 12.02
Volume:6,277,078
Avg Vol (3m):3,360,440
Market Cap:1.15B
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 4.41%1.15B
IMGNDown 2.44%654.41M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):878.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.55
Quarterly EPS Est (Mar-15) :-0.12
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, engages in the discovery and development of cancer therapies. The company is employing novel gene expression and control technology to deliver DNA for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback